BlackRock’s Psychemedics Corporation PMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-66,408
| Closed | -$153K | – | 5478 |
|
|
2024
Q3 | $153K | Sell |
66,408
-4,611
| -6% | -$10.4K | ﹤0.01% | 4584 |
|
|
2024
Q2 | $172K | Sell |
71,019
-5,729
| -7% | -$14.6K | ﹤0.01% | 4579 |
|
|
2024
Q1 | $225K | Sell |
76,748
-519
| -0.7% | -$1.65K | ﹤0.01% | 4555 |
|
|
2023
Q4 | $229K | Sell |
77,267
-114
| -0.1% | -$304 | ﹤0.01% | 4604 |
|
|
2023
Q3 | $307K | Sell |
77,381
-399
| -0.5% | -$1.78K | ﹤0.01% | 4562 |
|
|
2023
Q2 | $355K | Sell |
77,780
-399
| -0.5% | -$2.02K | ﹤0.01% | 4583 |
|
|
2023
Q1 | $410K | Sell |
78,179
-8,087
| -9% | -$44.8K | ﹤0.01% | 4576 |
|
|
2022
Q4 | $423K | Sell |
86,266
-169
| -0.2% | -$997 | ﹤0.01% | 4651 |
|
|
2022
Q3 | $557K | Sell |
86,435
-572
| -0.7% | -$3.68K | ﹤0.01% | 4694 |
|
|
2022
Q2 | $552K | Sell |
87,007
-1,409
| -2% | -$9.03K | ﹤0.01% | 4745 |
|
|
2022
Q1 | $609K | Sell |
88,416
-2,176
| -2% | -$15.4K | ﹤0.01% | 4825 |
|
|
2021
Q4 | $637K | Buy |
90,592
+976
| +1% | +$7.81K | ﹤0.01% | 4802 |
|
|
2021
Q3 | $752K | Buy |
89,616
+3
| +0% | +$22 | ﹤0.01% | 4643 |
|
|
2021
Q2 | $625K | Sell |
89,613
-13,179
| -13% | -$92.3K | ﹤0.01% | 4637 |
|
|
2021
Q1 | $637K | Buy |
102,792
+1,467
| +1% | +$9.72K | ﹤0.01% | 4578 |
|
|
2020
Q4 | $516K | Sell |
101,325
-1,033
| -1% | -$4.48K | ﹤0.01% | 4345 |
|
|
2020
Q3 | $451K | Sell |
102,358
-2,359
| -2% | -$11.5K | ﹤0.01% | 4285 |
|
|
2020
Q2 | $581K | Buy |
104,717
+4,265
| +4% | +$23.8K | ﹤0.01% | 4178 |
|
|
2020
Q1 | $608K | Sell |
100,452
-51
| -0.1% | -$430 | ﹤0.01% | 4016 |
|
|
2019
Q4 | $920K | Sell |
100,503
-1,225
| -1% | -$11.3K | ﹤0.01% | 4021 |
|
|
2019
Q3 | $927K | Sell |
101,728
-346
| -0.3% | -$2.94K | ﹤0.01% | 4001 |
|
|
2019
Q2 | $1.03M | Buy |
102,074
+71,619
| +235% | +$813K | ﹤0.01% | 4000 |
|
|
2019
Q1 | $427K | Buy |
30,455
+62
| +0.2% | +$1.07K | ﹤0.01% | 4121 |
|
|
2018
Q4 | $482K | Buy |
30,393
+301
| +1% | +$5.19K | ﹤0.01% | 4072 |
|
|
2018
Q3 | $565K | Buy |
30,092
+742
| +3% | +$14.8K | ﹤0.01% | 4117 |
|
|
2018
Q2 | $565K | Buy |
29,350
+329
| +1% | +$6.67K | ﹤0.01% | 4066 |
|
|
2018
Q1 | $619K | Sell |
29,021
-1,507
| -5% | -$31.3K | ﹤0.01% | 4010 |
|
|
2017
Q4 | $627K | Buy |
30,528
+400
| +1% | +$7.42K | ﹤0.01% | 4012 |
|
|
2017
Q3 | $554K | Sell |
30,128
-2,289
| -7% | -$50.4K | ﹤0.01% | 4045 |
|
|
2017
Q2 | $809K | Buy |
32,417
+4,257
| +15% | +$89.5K | ﹤0.01% | 3898 |
|
|
2017
Q1 | $564K | Buy |
+28,160
| New | +$618K | ﹤0.01% | 3931 |
|
Other funds holding PMD
BlackRock's PMD Position: Q4 2024 in Review
BlackRock sold out of Psychemedics Corporation (PMD) in Q4 2024, closing a stake of 66,408 shares — an estimated $153K sold.
BlackRock first reported a position in PMD in Q1 2017 and held it in 31 quarters. The position peaked at $1.03M in Q2 2019. 3 funds tracked by Wall St. Rank hold PMD as of Q4 2024.
- BlackRock reported no remaining Psychemedics Corporation position as of Q4 2024 after selling out during the quarter.
- BlackRock sold 66,408 Psychemedics Corporation shares in Q4 2024, an estimated $153K.
- BlackRock first reported a position in Psychemedics Corporation in Q1 2017 and held it in 31 quarters.
- BlackRock's Psychemedics Corporation position peaked at $1.03M in Q2 2019.
- 3 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2024.
Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.